Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis

Virology

Volumn 380, Issue 2, 2008, Pages 182-190

  Nguyen, YN ^a   McGuffie, Bryan A ^a   Anderson, Victoria E ^a   Weinberg, Jason B ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Chemokine; Gammaherpesvirus; Immunomodulation; Interferon; Latency

Indexed keywords

GAMMA INTERFERON;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HERPES VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS LOAD;

ADENOVIRIDAE; ANIMALS; CYTOKINES; DISEASE SUSCEPTIBILITY; GENE EXPRESSION PROFILING; LUNG; MALE; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHADINOVIRUS; SPLEEN;

ADENOVIRIDAE; MURINAE; MURINE ADENOVIRUS 1; MUS;

EID: 53349167502     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.07.031     Document Type: Article

References (33)

1. Barton E.S., White D.W., Cathelyn J.S., Brett-McClellan K.A., Engle M., Diamond M.S., Miller V.L., and Virgin H.W.t. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447 7142 (2007) 326-329
2. Berg R.E., Crossley E., Murray S., and Forman J. Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen. J Exp Med 198 10 (2003) 1583-1593
3. Boname J.M., Coleman H.M., May J.S., and Stevenson P.G. Protection against wild-type murine gammaherpesvirus-68 latency by a latency-deficient mutant. J. Gen. Virol. 85 Pt 1 (2004) 131-135
4. Casola A., Henderson A., Liu T., Garofalo R.P., and Brasier A.R. Regulation of RANTES promoter activation in alveolar epithelial cells after cytokine stimulation. Am J Physiol Lung Cell Mol Physiol 283 6 (2002) L1280-L1290
5. Cauthen A.N., Welton A.R., and Spindler K.R. Construction of mouse adenovirus type 1 mutants. Methods Mol Med 130 (2007) 41-59
6. Chen H.D., Fraire A.E., Joris I., Brehm M.A., Welsh R.M., and Selin L.K. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat Immunol 2 11 (2001) 1067-1076
7. Chen H.D., Fraire A.E., Joris I., Welsh R.M., and Selin L.K. Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lung. Am. J. Pathol. 163 4 (2003) 1341-1355
8. Cook C.H., Zhang Y., McGuinness B.J., Lahm M.C., Sedmak D.D., and Ferguson R.M. Intra-abdominal bacterial infection reactivates latent pulmonary cytomegalovirus in immunocompetent mice. J. Infect. Dis. 185 10 (2002) 1395-1400
9. Fink L., Seeger W., Ermert L., Hanze J., Stahl U., Grimminger F., Kummer W., and Bohle R.M. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 4 11 (1998) 1329-1333
10. Flano E., Husain S.M., Sample J.T., Woodland D.L., and Blackman M.A. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165 2 (2000) 1074-1081
11. Kajon A.E., Brown C.C., and Spindler K.R. Distribution of mouse adenovirus type 1 in intraperitoneally and intranasally infected adult outbred mice. J. Virol. 72 2 (1998) 1219-1223
12. Kajon A.E., and Spindler K.R. Mouse adenovirus type 1 replication in vitro is resistant to interferon. Virology 274 1 (2000) 213-219
13. Koffron A., Varghese T., Hummel M., Yan S., Kaufman D., Fryer J., Leventhal J., Stuart F., and Abecassis M. Immunosuppression is not required for reactivation of latent murine cytomegalovirus. Transplant. Proc. 31 1-2 (1999) 1395-1396
14. Lenaerts L., Verbeken E., De Clercq E., and Naesens L. Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections. Antimicrob. Agents Chemother. 49 11 (2005) 4689-4699
15. Lenaerts L., Daelemans D., Geukens N., De Clercq E., and Naesens L. Mouse adenovirus type 1 attachment is not mediated by the coxsackie-adenovirus receptor. FEBS Lett. 580 16 (2006) 3937-3942
16. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338 7 (1998) 436-445
17. Martin C.A., and Dorf M.E. Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage cell lines. Cell Immunol 135 1 (1991) 245-258
18. Navarini A.A., Recher M., Lang K.S., Georgiev P., Meury S., Bergthaler A., Flatz L., Bille J., Landmann R., Odermatt B., Hengartner H., and Zinkernagel R.M. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl. Acad. Sci. USA 103 42 (2006) 15535-15539
19. Parry C.M., Simas J.P., Smith V.P., Stewart C.A., Minson A.C., Efstathiou S., and Alcami A. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J. Exp. Med. 191 3 (2000) 573-578
20. Ptaschinski C., and Rochford R. Infection of neonates with murine gammaherpesvirus 68 results in enhanced viral persistence in lungs and absence of infectious mononucleosis syndrome. J Gen Virol 89 Pt 5 (2008) 1114-1121
21. Pype J.L., Dupont L.J., Menten P., Van Coillie E., Opdenakker G., Van Damme J., Chung K.F., Demedts M.G., and Verleden G.M. Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 21 4 (1999) 528-536
22. Rickinson A.B., and Kieff E. Epstein-Barr virus. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 4th ed. Vol. 2 (2001), Lippincott Williams and Wilkins, Philadelphia 2575-2627 2 vols
23. Rochford R., Lutzke M.L., Alfinito R.S., Clavo A., and Cardin R.D. Kinetics of murine gammaherpesvirus 68 gene expression following infection of murine cells in culture and in mice. J. Virol. 75 11 (2001) 4955-4963
24. Sarawar S.R., Lee B.J., Anderson M., Teng Y.C., Zuberi R., and Von Gesjen S. Chemokine induction and leukocyte trafficking to the lungs during murine gammaherpesvirus 68 (MHV-68) infection. Virology 293 1 (2002) 54-62
25. Selin L.K., Brehm M.A., Naumov Y.N., Cornberg M., Kim S.K., Clute S.C., and Welsh R.M. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol Rev 211 (2006) 164-181
26. Stellato C., Beck L.A., Gorgone G.A., Proud D., Schall T.J., Ono S.J., Lichtenstein L.M., and Schleimer R.P. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J Immunol 155 1 (1995) 410-418
27. Stewart J.P., Usherwood E.J., Ross A., Dyson H., and Nash T. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187 12 (1998) 1941-1951
28. Tibbetts S.A., Loh J., Van Berkel V., McClellan J.S., Jacoby M.A., Kapadia S.B., Speck S.H., and Virgin H.W. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J. Virol. 77 13 (2003) 7696-7701
29. Tschernig T., and Pabst R. Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases. Pathobiology 68 1 (2000) 1-8
30. Van Berkel V., Barrett J., Tiffany H.L., Fremont D.H., Murphy P.M., McFadden G., Speck S.H., and Virgin H.W. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J. Virol. 74 15 (2000) 6741-6747
31. Weinberg J.B., Lutzke M.L., Efstathiou S., Kunkel S., and Rochford R. Elevated chemokine responses are maintained in lungs after clearance of viral infection. J. Virol. 76 20 (2002) 10518-10523
32. Weinberg J.B., Lutzke M.L., Alfinito R., and Rochford R. Mouse strain differences in the chemokine response to acute lung infection with a murine gammaherpesvirus. Viral Immunol. 17 1 (2004) 69-77
33. Weinberg J.B., Stempfle G.S., Wilkinson J.E., Younger J.G., and Spindler K.R. Acute respiratory infection with mouse adenovirus type 1. Virology 340 2 (2005) 245-254